ERT-Bioclinica marriage, led by Nordic and Astorg, pushes valuation to $5.9bn

The merger of the clinical trial technology companies comes as CROs and the broader pharma industry face growing pressure to shift to a cloud-based approach to speed up decision-making in drug development.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this